Clinical Trials on Metaplastic Carcinoma of the Breast in Finland

Total 331 results

Turku University Hospital

Completed

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

Finland
Finnish Breast Cancer Group

Completed

BREAST CANCER AND EXERCISE (BREX)

Improve Quality of Life | Prevent Osteoporosis and Osteoporotic Fractures | Improve Weight Control, and Muscular and Cardiovascular Fitness | Help the Patients to Return to Working Life | Reduce the Risk of Breast Cancer Recurrence | Reduce All-cause Mortality in Patients With Primary Breast...

Finland
Nexstim Ltd

Enrolling by invitation

Use of Nexstim SNBT System

Usability of the Graphical User Interface of the Device for Its Intended Use

Finland
Helsinki University Central Hospital

Recruiting

Finnish Patient-Reported Outcomes Initiative for Shoulder and Elbow (φ-PROMISE)

Cultural Adaptation of Shoulder and Elbow PROMs | Definition of the Patients Acceptable Symptomatic State | Definition of the Minimal Important Difference

Finland
Pfizer

Completed

A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Kidney Cancer | Kidney Neoplasms | Renal Cell Carcinoma | Renal Cancer | Renal Cell Cancer | Cancer of the Kidney | Cancer of Kidney

Finland
Turku University Hospital

Unknown

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Mammary Ductal Carcinoma

Finland
University of Jyvaskyla
Helsinki University Central Hospital

Completed

Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients

Breast Cancer

Finland
Helsinki University Central Hospital

Recruiting

Treatment of Medial Epicondyle Fractures in Children and Adolescents

Medial Epicondyle Fracture of the Humerus | 7 to16 Year Old Children and Adolecents | More Than 2 mm of Displacement

Finland
University of Oulu

Recruiting

Lingual Frenulum in Newborn Infants (LINNE) (LINNE)

Breast Feeding | Frenulum Breve | Tongue Tie | Frenulum; Elongation

Finland
Turku University Hospital

Active, not recruiting

Effect of Cladribine Treatment on Microglial Activation in the CNS (CLADPET)

Multiple Sclerosis

Finland
Turku University Hospital

Active, not recruiting

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression (TERIPET)

Multiple Sclerosis

Finland
Turku University Hospital

Enrolling by invitation

Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients (FUP-MS)

Multiple Sclerosis

Finland
Turku University Hospital

Unknown

Liquid Biopsy in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Finland
Turku University Hospital

Recruiting

Multimodal Imaging of MS Reveals the Smoldering Inflammation (PLAQ-MS)

Multiple Sclerosis

Finland
Tampere University Hospital
Turku University Hospital; Kuopio University Hospital; Jyväskylä Central Hospital

Active, not recruiting

Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO) (FIBRATIO)

Quality of Life | Breast Cancer | Patient Satisfaction | Multidisciplinary Communication | Resection Margin | Surgical Margin

Finland
Turku University Hospital

Recruiting

18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC (HENEPET)

Head and Neck Squamous Cell Carcinoma

Finland
Tampere University Hospital
Olfactomics Oy

Recruiting

Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis

Oral Squamous Cell Carcinoma

Finland
Gulam Manji
Regeneron Pharmaceuticals; BioLine Rx

Recruiting

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Adenocarcinoma | Pancreatic Cancer | Adenocarcinoma of the Pancreas

United States
Turku University Hospital

Completed

Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation (FINGOPET)

Multiple Sclerosis

Finland
University of Turku

Unknown

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Multiple Sclerosis

Finland
University of Nebraska
National Cancer Institute (NCI)

Active, not recruiting

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditions

United States
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps (FORTE)

Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States
Soligenix

Completed

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

Oral Mucositis | Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

United States, Spain, United Kingdom, France, Belgium
Johann Wolfgang Goethe University Hospital

Completed

cSEMS vs. NEPS in Stricture of Biliary Anastomosis After Liver Transplantation

Stenosis of the Bilio-biliary Anastomosis After Orthotopic Liver Transplantation

Finland, Germany, Italy
Turku University Hospital

Active, not recruiting

Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis (PROMS)

Multiple Sclerosis

Finland
Bayer
Novartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe Ltd

Completed

EPID Multiple Sclerosis Pregnancy Study

Multiple Sclerosis

Finland
Numab Therapeutics AG

Recruiting

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Renal Cell Carcinoma | Mesothelioma, Malignant | Adenocarcinoma of Lung | Triple Negative Breast Cancer | Endometrial Cancer | Fallopian Tube Carcinoma | Peritoneal Carcinoma | Leiomyosarcoma | Liposarcoma | Ovarian Carcinoma | Adenocarcinoma of the Stomach | Melanoma, Malignant | Adenocarcinoma - Gastroesophageal...

United States
National Cancer Institute (NCI)

Active, not recruiting

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast Carcinoma | Metastatic BRCA Hereditary Breast Carcinoma

United States, Puerto Rico
Tampere University Hospital
University of Turku; University of Helsinki; Tampere University; Aalto University

Recruiting

Measuring Oncological Value of Exercise and Statin (MOVES)

Kidney Cancer | Breast Cancer | Metastatic Renal Cell Carcinoma | Ovarian Cancer | Prostate Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Ovarian Cancer | Metastatic Renal Cancer | Metastatic Kidney Cancer | Metastatic Ovary Cancer

Finland
Region Örebro County
Helsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaborators

Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients (IMPORTANT)

Quality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older Patients

Sweden, Finland, Greece, Italy, Norway, Spain
Bayer
Biogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.

Not yet recruiting

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden (INFORM)

Multiple Sclerosis (MS)

Sweden, Finland
Helsinki University Central Hospital

Withdrawn

Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?

Pancreatic Cancer | Biliary Stasis

Finland
Tampere University
Turku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaborators

Enrolling by invitation

Development of Knee Osteoarthritis After Arthroscopic Partial Resection of Degenerative Meniscus Tear

Osteoarthritis of the Knee | Meniscal Tear | Arthroscopy

Finland
Arthrex, Inc.

Recruiting

Web Based Orthopaedic Sports Medicine Registry

Degenerative and Traumatic Pathology of the Knee | Degenerative and Traumatic Pathology of the Shoulder and Elbow | Degenerative and Traumatic Pathology of the Foot and Ankle | Degenerative and Traumatic Pathology of the Hand and Wrist | Degenerative and Traumatic Pathology of the Hip

United States, United Kingdom, Canada, Puerto Rico, South Africa
Turku University Hospital

Completed

Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis (ROMUS)

Multiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

Finland
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma

United States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Active, not recruiting

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Ductal Breast Carcinoma In Situ

United States
TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Breast Carcinoma

United States
Biogen

Completed

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies (RECOVER)

Relapsing-Remitting Multiple Sclerosis

Finland
University of Eastern Finland

Completed

Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients (PAMS)

Quality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple Sclerosis

Finland
Finnish MS Society
Seinajoki Central Hospital; Social Insurance Institution, Finland; Tampere University...

Completed

The Effects of Attention Retraining in MS (MSattention)

Multiple Sclerosis

Finland
Kuopio University Hospital

Completed

Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis (FingoHRV)

Relapse-remitting Multiple Sclerosis

Finland
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

United States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
University of Oulu

Active, not recruiting

Sequelae of Developmental Dysplasia of the Hip

Hip Dysplasia | Developmental Dysplasia of the Hip

Finland
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Canadian Cancer Trials Group

Active, not recruiting

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma | Ductal Breast Carcinoma | Tubular Breast Carcinoma | Medullary Breast Carcinoma

United States, Canada
AO Clinical Investigation and Publishing Documentation
AOCMF

Active, not recruiting

Medication-related Osteonecrosis of the Jaw (MRONJ) Registry (MRONJ)

Bisphosphonate-Associated Osteonecrosis of the Jaw | Medication-related Osteonecrosis of the Jaw

Germany, Qatar, Switzerland, Finland, United States, Slovenia, Spain, Netherlands, Romania, Korea, Republic of
GlaxoSmithKline
iTeos Therapeutics

Recruiting

Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Neoplasms, Head and Neck

United States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
Bristol-Myers Squibb

Completed

Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (CheckMate 714)

Head and Neck Cancer

United States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
Gulam Manji
Merck Sharp & Dohme LLC

Completed

Perioperative Chemo and Pembrolizumab in Gastric Cancer

Gastric Cancer | Adenocarcinoma of the Gastroesophageal Junction

United States

Clinical Trials on Metaplastic Carcinoma of the Breast in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations